Locus Cell Co (6891.TWO) Stock Price

Locus Cell Co Price

CLOSED
36.65
​
Market closed

Revenue has compounded at 98.2% per year over the past 2 years to 2.36 M TWD. Locus Cell Co's net margin stands at -4,797.0%, up from -8,913.0% several years earlier.

Locus Cell Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Locus Cell Co business model & stock analysis

Locus Cell Co., Ltd. principally engages in the entrusted development and manufacturing of cell therapy-related products. The company is headquartered in Taipei, New Taipei and currently employs 32 full-time employees. The company went IPO on 2022-04-28. The firm is currently expected to provide cell therapy contract manufacturing organization (CDMO) production and development services using a pilot Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S) good manufacturing practices (GMP) facility, with related technologies for cell therapy products (expected to include tissue engineering related products, CAR-T, iPSCs, MSC and other cell therapy applications), process development and process scale-up, analytical method development and validation, clinical GMP manufacturing process for clinical trials, and stability testing.

Frequently asked questions about Locus Cell Co

Converted at the current exchange rate, the Locus Cell Co share trades at 1.01 EUR (36.65 TWD).

The revenue cannot currently be calculated for Locus Cell Co.

The profit cannot currently be calculated for Locus Cell Co.

The P/E ratio cannot be calculated for Locus Cell Co at the moment.

The P/S cannot be calculated for Locus Cell Co currently.

The Eulerpool Quality Score for Locus Cell Co is 2/10.

The ISIN of Locus Cell Co is TW0006891005. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Locus Cell Co is 6891.TWO. The ticker symbol is used to trade Locus Cell Co shares on the stock exchange.

Fair ValueTerminal
33.72 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue per Employee
73,625.00 TWD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Apr 28, 2022
ISIN
TW0006891005
Cusip
Y53268101
Market capitalization
7.33 B TWDMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
4.26
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-6.31 %
Last updated Nov 15, 2026, 3:35 AM

Locus Cell Co Peer Group

Locus Cell Co FIGI

6891:TT (Taipei Stock Exchange) · BBG016XDQ8Z6